Need for a Multiparametric Ultrasound-Based Assessment of MAFLD: The Backbone of Strategic Management
1. Abstract Metabolic dysfunction-associated fatty liver disease (MAFLD) is an escalating global health concern, impacting approximately 25-30% of the global population.